Trials / Terminated
TerminatedNCT02323776
Defining the Radiotherapy Dose and Volume Parameters Affecting Postoperative Complications in Esophageal Cancer Patients
Correlation of Radiotherapy-related Features With Postoperative Complications in Patients With Esophageal Cancer Treated With Trimodality Therapy
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Maastricht Radiation Oncology · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to identify features of the cumulative dose-volume histogram (DVH) for patients treated with trimodality therapy in oesophageal cancer and correlate these with postoperative complications.
Detailed description
Intention to treat analysis in patients initially assigned to be treated with the trimodality protocol: neoadjuvant chemoradiotherapy followed by surgery. The investigators will retrospectively evaluate several parameters of the treatment planning of patients treated with a preoperative regimen (CROSS regimen 41,4 Gy in 23 fractions or 50, 4 Gy in 28 fractions ): * PTV volume1 * MLD, V30, V20, V15, V10, VS5 (Volume lung less dan 5 Gy)2 (lung toxicity) * MHD, V20, V30, V403 (heart toxicity) * Mean stomach dose, V50 stomach * Mitochondrial DNA if available per patient Pre-existing cardiac,pulmonary comorbidity, smoking behavior, BMI, type of surgery and chemotherapy (especially taxanes) will be scored and take into account in a multivariate analysis. The investigators will collect these data and correlate the data with the presence of postoperative complications, time of onset of complications and duration of hospitalization. These latter data are already scored in a prospective manner at the Atrium Medical Center in Heerlen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Trimodality protocol | neoadjuvant chemoradiotherapy followed by surgery |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-09-01
- Completion
- 2015-12-01
- First posted
- 2014-12-23
- Last updated
- 2016-03-18
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02323776. Inclusion in this directory is not an endorsement.